Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

After a decade of relying on blood transfusions for her congenital disorder, 11-year-old Dang Thanh Mai Thu is now recovering from a life-saving bone marrow transplant.

ACTIVATE-Kids is the First Study to Demonstrate Efficacy of an Oral Therapy for Children with PK Deficiency Who Are Not Regularly Transfused –– ...

The Ministry of Health in Kuwait has approved the executive regulations for Law No. 31 of 2008, which governs premarital ...

Looking for a good area in which to invest? Consider the healthcare sector. People must have healthcare. And with aging ...

Dr Ravinder K Gupta, Dr Akhilpreet Kaur Anemia is a serious global public health problem that particularly affects young ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent beta-thalassemia in August 2022, and exagamglogene autotemcel (exa-cel ...

Tanvi was diagnosed with thalassemia at just six months. Born into a family facing daily financial struggles, Tanvi’s road to better health has been challenging: her father, Bhupinder Shantilal ...

A Thalassemia screening desk has been inaugurated at the NADRA centre in Sukkur on Saturday marking a significant step forwards the fight against the genetic disorder. The desk, established in ...